De novo enzymes: from computational design to mRNA display

Trends in Biotechnology

Volumn 28, Issue 7, 2010, Pages 340-345

  Golynskiy, Misha V ^a   Seelig, Burckhard ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYTIC ANTIBODIES; CHEMICAL CATALYST; COMBINATORIAL APPROACH; COMPUTATIONAL DESIGN; DIRECTED EVOLUTION; ENVIRONMENTALLY RESPONSIBLE; INDUSTRIAL SETTINGS; MRNA-DISPLAY; NATURAL ENZYME; PROTEIN DESIGN; PROTEIN ENGINEERING; PROTEIN LIBRARY;

CATALYSTS; DESIGN; ENZYMES; GENETIC ENGINEERING;

BIOCHEMICAL ENGINEERING;

CATALYTIC ANTIBODY; MESSENGER RNA;

ANTIBODY PRODUCTION; BIOCATALYST; BIOTECHNOLOGY; CATALYSIS; COMBINATORIAL CHEMISTRY; COMPUTER AIDED DESIGN; DNA LIBRARY; ENZYME MODIFICATION; INTERMETHOD COMPARISON; MESSENGER RNA DISPLAY; PRIORITY JOURNAL; PROTEIN ENGINEERING; REVIEW;

ANIMALS; COMPUTATIONAL BIOLOGY; ENZYMES; INDUSTRY; MICE; PROTEIN ENGINEERING; RNA, MESSENGER;

EID: 77953911271     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2010.04.003     Document Type: Review

References (53)

1. Aehle W. Enzymes in Industry 2007, Wiley-VCH Verlag GmbH & Co. KGaA.
2. Damborsky J., Brezovsky J. Computational tools for designing and engineering biocatalysts. Curr. Opin. Chem. Biol. 2009, 13:26-34.
3. Marti S., et al. Computational design of biological catalysts. Chem. Soc. Rev. 2008, 37:2634-2643.
4. Alexey B., et al. Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde. BioEssays 2009, 31:1161-1171.
5. Wójcik T., Kiec-Kononowicz K. Catalytic activity of certain antibodies as a potential tool for drug synthesis and for directed prodrug therapies. Curr. Med. Chem. 2008, 15:1606-1615.
6. Pauling L. Nature of forces between large molecules of biological interest. Nature 1948, 161:707-709.
7. Pauling L. Molecular architecture and biological reactions. Chem. Eng. News 1946, 24:1375-1377.
8. Rothlisberger D., et al. Kemp elimination catalysts by computational enzyme design. Nature 2008, 453:190-195.
9. Jiang L., et al. De novo computational design of retro-aldol enzymes. Science 2008, 319:1387-1391.
10. Zanghellini A., et al. New algorithms and an in silico benchmark for computational enzyme design. Protein Sci. 2006, 15:2785-2794.
11. Lassila J., et al. Origins of catalysis by computationally designed retroaldolase enzymes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:4937-4942.
12. Faiella M., et al. An artificial di-iron oxo-protein with phenol oxidase activity. Nat. Chem. Biol. 2009, 5:882-884.
13. Tramontano A., et al. Catalytic antibodies. Science 1986, 234:1566-1570.
14. Pollack S.J., et al. Selective chemical catalysis by an antibody. Science 1986, 234:1570-1573.
15. Jencks W.P. Catalysis in chemistry and enzymology 1969, McGraw-Hill.
16. Xu Y., et al. Catalytic antibodies: hapten design strategies and screening methods. Bioorg. Med. Chem. 2004, 12:5247-5268.
17. Cesaro-Tadic S., et al. Turnover-based in vitro selection and evolution of biocatalysts from a fully synthetic antibody library. Nat. Biotechnol. 2003, 21:679-685.
18. Seelig B., Szostak J.W. Selection and evolution of enzymes from a partially randomized non-catalytic scaffold. Nature 2007, 448:828-831.
19. Roberts R.W., Szostak J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:12297-12302.
20. Nemoto N., et al. In vitro virus: bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett. 1997, 414:405-408.
21. Cho G.S., Szostak J.W. Directed evolution of ATP binding proteins from a zinc finger domain by using mRNA display. Chem. Biol. 2006, 13:139-147.
22. Zahnd C., et al. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat. Methods 2007, 4:269-279.
23. Keefe A.D., Szostak J.W. Functional proteins from a random-sequence library. Nature 2001, 410:715-718.
24. Kazlauskas R.J., Bornscheuer U.T. Finding better protein engineering strategies. Nat. Chem. Biol. 2009, 5:526-529.
25. Morley K.L., Kazlauskas R.J. Improving enzyme properties: when are closer mutations better? Trends Biotechnol. 2005, 23:231-237.
26. Khersonsky O., et al. Evolutionary optimization of computationally designed enzymes: Kemp eliminases of the KE07 series. J. Mol. Biol. 2010, 396:1025-1042.
27. Miller O.J., et al. Directed evolution by in vitro compartmentalization. Nat. Methods 2006, 3:561-570.
28. Otten L.G., et al. Enzyme engineering for enantioselectivity: from trial-and-error to rational design?. Trends Biotechnol. 2010, 28:46-54.
29. Iyer P.V., Ananthanarayan L. Enzyme stability and stabilization - aqueous and non-aqueous environment. Process Biochem. 2008, 43:1019-1032.
30. Rubin-Pitel S.B., Zhao H.M. Recent advances in biocatalysis by directed enzyme evolution. Comb. Chem. High Throughput Screen. 2006, 9:247-257.
31. Turner N.J. Directed evolution drives the next generation of biocatalysts. Nat. Chem. Biol. 2009, 5:567-573.
32. Brakmann S., Johnsson K. Directed Molecular Evolution of Proteins 2002, Wiley-VCH Verlag GmbH.
33. Bloom J.D., et al. Evolving strategies for enzyme engineering. Curr. Opin. Struct. Biol. 2005, 15:447-452.
34. Wang T.-W., et al. Mutant library construction in directed molecular evolution. Mol. Biotechnol. 2006, 34:55-68.
35. Reetz M.T., Carballeira J.D. Iterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymes. Nat. Protocols 2007, 2:891-903.
36. Fox R.J., et al. Improving catalytic function by ProSAR-driven enzyme evolution. Nat. Biotechnol. 2007, 25:338-344.
37. Daugherty P.S. Protein engineering with bacterial display. Curr. Opin. Struct. Biol. 2007, 17:474-480.
38. Gai S.A., Wittrup K.D. Yeast surface display for protein engineering and characterization. Curr. Opin. Struct. Biol. 2007, 17:467-473.
39. Paschke M. Phage display systems and their applications. Appl. Microbiol. Biotechnol. 2006, 70:2-11.
40. Huang B.C., Liu R. Comparison of mRNA-display-based selections using synthetic peptide and natural protein libraries. Biochemistry 2007, 46:10102-10112.
41. Cho G., et al. Constructing high complexity synthetic libraries of long ORFs using in vitro selection. J. Mol. Biol. 2000, 297:309-319.
42. Kurz M., et al. Psoralen photo-crosslinked mRNA-puromycin conjugates: a novel template for the rapid and facile preparation of mRNA-protein fusions. Nucleic Acids Res. 2000, 28:e83.
43. Tabata N., et al. Rapid antibody selection by mRNA display on a microfluidic chip. Nucleic Acids Res. 2009, 37:e64.
44. Liao H.I., et al. mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein. J. Biol. Chem. 2009, 284:17512-17520.
45. Millward S.W., et al. Design of cyclic peptides that bind protein surfaces with antibody-like affinity. ACS Chem. Biol. 2007, 2:625-634.
46. Takahashi T.T., et al. mRNA display: ligand discovery, interaction analysis and beyond. Trends Biochem. Sci. 2003, 28:159-165.
47. Josephson K., et al. Ribosomal synthesis of unnatural peptides. J. Am. Chem. Soc. 2005, 127:11727-11735.
48. Frankel A., et al. Encodamers: unnatural peptide oligomers encoded in RNA. Chem. Biol. 2003, 10:1043-1050.
49. Wentworth P., Janda K. Catalytic antibodies, structure and function. Cell Biochem. Biophys. 2001, 35:63-87.
50. Hilvert D. Crictical analysis of antibody catalysis. Annu. Rev. Biochem. 2000, 69:751-793.
51. Guofu Z., et al. Broadening the aldolase catalytic antibody repertoire by combining reactive immunization and transition state theory: new enantio- and diastereoselectivities. Angew. Chem. Int. Ed. 1999, 38:3738-3741.
52. Miller B.G., Wolfenden R. Catalytic proficiency: the unusual case of OMP decarboxylase. Annu. Rev. Biochem. 2002, 71:847-885.
53. Snider M.J., Wolfenden R. The rate of spontaneous decarboxylation of amino acids. J. Am. Chem. Soc. 2000, 122:11507-11508.